Bill · H.R. 1796· House(119-HR-1796)
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
- Introduced
- 3/3/2025
- Last activity
- 3/3/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- John James
- Cosponsors
- - 1 - 5
- Introduced
- In Committee
What this bill would do
This bill seeks to amend the Public Health Service Act to reauthorize a demonstration program. It aims to expand the focus of the program to include the prevention and treatment of complications related to sickle cell disease. The legislation also updates the methods for providing support by allowing for grants, contracts, or cooperative agreements. Furthermore, it increases the funding allocated to the program for specific fiscal years. The bill is titled the "Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025".
Yes· 3 of 5
Does this put more money into medical research?+6
The bill increases annual funding for the sickle cell disease demonstration program from $4,455,000 to $8,205,000.
Does this make health care easier to get in general?+5
The bill expands the scope of the demonstration program to include the prevention and treatment of complications of sickle cell disease.
Would Black Americans be better off under this?+5
The bill increases resources for treating sickle cell disease and its complications, a condition that highly impacts the Black community.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Expanded Medical Focus: The bill changes the language to include the "prevention and treatment of complications of sickle cell disease" (Section 2(a)(1), 2(a)(2), and 2(a)(3)(B)). This could benefit patients by addressing the various complications that arise from the disease rather than just the disease itself.
-
Increased Flexibility in Funding: By allowing the program to "make a grant to, or enter into a contract or cooperative agreement with" entities (Section 2(a)(3)(A)), the program gains more ways to distribute resources to those in need.
-
Increased Funding Levels: The bill increases the amount from $4,455,000 to $8,205,000 for the specified fiscal years (Section 2(a)(4)). This provides more financial resources for the demonstration program between fiscal years 2025 and 2029.
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Increases Research Funding+6Improves Healthcare Access+5
- Demographic And Interest Groups
- Good For African Americans+5Good For Low Income Households+3
- Social Issues And Justice
- Improves Racial Equity+4
- 1/16/2026
- 1 Cosponsor added.
- 8/15/2025
- 1 Cosponsor added.
- 3/3/2025
- Referred to the House Committee on Energy and Commerce.
- 4 Cosponsors added.
- Introduced in House
4 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Sanford BishopDemocrat · Georgia
Troy CarterDemocrat · Louisiana
Danny DavisDemocrat · Illinois
Jennifer KiggansRepublican · Virginia
Marc VeaseyDemocrat · Texas
Eugene VindmanDemocrat · Virginia